Given the broad-spectrum anticancer and preventive properties of SFN, we evaluated the inhibitory effects of SFN on IFN-γ-induced PD-L1 expression in a diverse range of tumor types, rather than focusing solely on a single tumor type. The gene discussed is IFNG; the disease is neoplasm.